Subscribe to these results:

Upcoming Workshops

For All Cancers

  1. May19Understanding the Role of Immunotherapy in Treating Cancer
    Part I of New Trends in ImmunotherapyRegister

For Lung Cancer

  1. Jun15Advances in the Treatment of Lung Cancer
    Part I of Living with Lung CancerRegister

For Lymphoma

  1. Jun23Update on Marginal Zone Lymphoma (MZL)
    Register

For Mantle Cell Lymphoma

  1. Update on CAR T-Cell Therapies
  2. May12Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    Register
  3. May13Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    Register
  4. May20Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    Register
  5. Jun11Update on the Treatment of Acute Myelogenous Leukemia (AML)
    Register

For Melanoma

  1. Jun14New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    Part I of Living with Advanced Skin Cancer and MelanomaRegister
  2. Jun25Emerging Treatments for Metastatic Melanoma
    Part II of Living with Advanced Skin Cancer and MelanomaRegister

Past workshops

For All Cancers

    1. Taking Your Pills on Schedule: Why It Is So Important in Managing Cancer
    2. Emerging Importance of Telemedicine/Telehealth Appointments in Communicating with Your Health Care Team
    3. Cancer and Flu Shots
    4. Treatment Adherence: Taking Your Pills on Schedule – Why It Is So Important
    5. What are Biosimilars? Understanding Their Role in Cancer Treatment: Current and Future Perspectives
    6. Managing the Side Effects of Immunotherapy
      Part II of New Trends in Immunotherapy
    7. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of New Trends in Immunotherapy
    8. Participating in Decisions about Your Care
      Part IV of Life with Cancer: A Guide to Getting the Best Care
    9. Understanding the Costs of Care and Your Health Care Coverage
      Part II of Life with Cancer: A Guide to Getting the Best Care
    10. Taking Your Treatment on Schedule: Its Importance in Managing Cancer
    11. Care for Your Bones During & After Cancer Treatment: Tips to Improve Bone Health
    12. Participating in Decisions about Your Care
      Part V of Life with Cancer: A Guide to Getting the Best Care
    13. Update on Clinical Trials: How They Work
    14. Managing the Side Effects of Immunotherapy
      Part II of Immunotherapy: A Promising Approach to Treating Cancer
    15. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of Immunotherapy: A Promising Approach to Treating Cancer
    16. Taking Your Pills on Schedule: Its Importance in Treating Cancer
    17. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    18. Genomics and the Future of Cancer Treatment
    19. Genomics and Genetics: What is the Difference?
    20. What Are Biosimilars? Understanding Their Role in Cancer Treatments: Current and Future Perspectives
    21. Managing the Side Effects of Immunotherapy
      Part II of Immunotherapy: A Promising New Approach to Treating Cancer
    22. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of Immunotherapy: A Promising New Approach to Treating Cancer
    23. Taking Your Pills on Schedule: Why It Is So Important in Managing Cancer
    24. What Are Generic Drugs: Understanding Their Role in Cancer Treatment
    25. Taking Your Pills on Schedule: The Importance of Adherence in the Treatment of Cancer
    26. Managing the Side Effects of Immunotherapy
      Part II of Immunotherapy: A Promising New Approach to Treating Cancer
    27. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of Immunotherapy: A Promising New Approach to Treating Cancer
    28. What Are Biosimilars? Understanding Their Role in Cancer Treatment: Current and Future Perspectives
    29. Taking Your Pills on Schedule – Why It Is So Important in Managing Cancer
    30. Understanding the Important Role of Adherence in the Medical Management of Cancer
    31. Medical Emergencies in Cancer Treatment

For Acute Lymphoblastic Leukemia

    1. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    2. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    3. Update on CAR-T Cell Therapy
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Taking Your Blood Cancer Treatment on Schedule
    6. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    9. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    10. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    11. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
    12. Update on CAR-T Cell Therapy
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Acute Myeloid Leukemia

    1. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    2. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    3. Living with Acute Myelogenous Leukemia (AML)
    4. Update on CAR-T Cell Therapy
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Taking Your Blood Cancer Treatment on Schedule
    7. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    8. Updates in the Treatment of Acute Myelogenous Leukemia
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Medical Update on Acute Myelogenous Leukemia (AML)
    11. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    12. Update on CAR-T Cell Therapy
    13. Medical Update on Acute Myelogenous Leukemia (AML)
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Basal Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    2. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Life with Advanced Skin Cancer
    3. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Advanced Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer

For Bladder Cancer

    1. Update on the Treatment of Bladder Cancer
      Part I of Living with Bladder Cancer
    2. What’s New in the Treatment of Bladder Cancer
      Part I of Life with Bladder Cancer
    3. Updates on the Treatment of Bladder Cancer
    4. Update on the Treatment of Bladder Cancer
      Part I of Living with Bladder Cancer

For Brain Cancer

    1. Update on Glioblastoma in Adults
    2. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    3. Update on Glioblastoma in Adults
    4. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    5. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment

For Breast Cancer

    1. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    2. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    3. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    4. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    5. Triple Negative Breast Cancer and African American Women
    6. What’s New in the Treatment of Breast Cancer for Women of All Ages
    7. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer – Updates from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
    8. The Latest Developments Reported at the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer – Updates from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
    9. What’s New in the Treatment of Metastatic Breast Cancer
    10. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    11. Update on Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    12. The Latest Developments Reported at the 41st Annual San Antonio Breast Cancer Symposium (SABCS)
    13. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment
    14. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer
      Part II of Highlights from the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
    15. The Latest Developments Reported at the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Highlights from the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
    16. Advances in the Treatment of Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    17. Advances in the Treatment of HER2 Positive Breast Cancer
    18. El cáncer de seno y las mujeres hispanas (Breast Cancer and Hispanic Women)

For Chronic Lymphocytic Leukemia

    1. Current Perspectives on the Treatment of Chronic Lymphocytic Leukemia (CLL)
      Part II of Living with Chronic Lymphocytic Leukemia (CLL)
    2. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    3. Update on Chronic Lymphocytic Leukemia (CLL)
      Part I of Living with Chronic Lymphocytic Leukemia (CLL)
    4. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    5. Update on CAR-T Cell Therapy
    6. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Update on Chronic Lymphocytic Leukemia
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    9. Taking Your Blood Cancer Treatment on Schedule
    10. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Living with Chronic Lymphocytic Leukemia
    13. Update on Chronic Lymphocytic Leukemia
      Part I of Living with Chronic Lymphocytic Leukemia
    14. Update on Chronic Lymphocytic Leukemia (CLL) from the 2018 American Society of Hematology (ASH) Annual Meeting
    15. Update on Chronic Lymphocytic Leukemia (CLL)
    16. Older Persons Living with Chronic Lymphocytic Leukemia
    17. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    18. Life with CLL: Taking Charge of Your Treatment Schedule
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    19. Managing Chronic Lymphocytic Leukemia and Its Complications
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    20. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    21. Update on CAR-T Cell Therapy
    22. Update on Chronic Lymphocytic Leukemia (CLL)
    23. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    24. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Chronic Myelogenous Leukemia

    1. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    2. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    3. Living with Chronic Myelogenous Leukemia (CML)
    4. Update on CAR-T Cell Therapy
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Taking Your Blood Cancer Treatment on Schedule
    7. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    10. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    11. Update on CAR-T Cell Therapy
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Colorectal Cancer

    1. Advances in the Treatment of Colorectal Cancer
    2. Progress in the Treatment of Colorectal Cancer
    3. Advances in the Treatment of Colorectal Cancer
    4. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    5. Update on the Treatment of Colorectal Cancer

For Cutaneous T-Cell Lymphoma

    1. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    2. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    3. Update on CAR-T Cell Therapy
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Taking Your Blood Cancer Treatment on Schedule
    6. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Update on Cutaneous T-Cell Lymphoma
    9. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    10. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    11. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    12. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    13. Update on CAR-T Cell Therapy
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Update on Cutaneous T-Cell Lymphoma
    16. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Advances in Immunotherapy in the Treatment of Lymphoma

For Diffuse Large B-Cell Lymphoma

    1. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    2. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    3. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    4. Update on CAR-T Cell Therapy
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Taking Your Blood Cancer Treatment on Schedule
    7. Update on Diffuse Large B-Cell Lymphoma
    8. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    11. Update on Diffuse Large B-Cell Lymphoma
    12. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    13. Update on CAR-T Cell Therapy

For Endometrial Cancer

    1. Update on the Treatment of Endometrial Cancer

For Follicular Lymphoma

    1. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    2. Progress in the Treatment of Follicular Lymphoma
    3. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    4. Update on CAR-T Cell Therapy
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Taking Your Blood Cancer Treatment on Schedule
    7. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Progress in the Treatment of Follicular Lymphoma
    10. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    11. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    12. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    13. Update on CAR-T Cell Therapy
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Progress in the Treatment of Follicular Lymphoma
    16. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Advances in Immunotherapy in the Treatment of Lymphoma

For Gastric Cancer

    1. Advances in the Treatment of Gastric Cancer
    2. Advances in the Treatment of Gastric Cancer
    3. Current Perspectives in the Treatment of Metastatic Gastric Cancer
    4. Advances in the Treatment of Gastric Cancer

For Gastrointestinal Stromal Tumors

    1. Advances in the Treatment of Gastrointestinal Stromal Tumors (GIST)
    2. Living with Gastrointestinal Stromal Tumors (GIST)

For Glioblastoma

    1. Update on Glioblastoma in Adults
    2. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    3. Update on Glioblastoma in Adults
    4. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    5. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment

For Head and Neck Cancer

    1. Treatment Update in Oral and Head and Neck Cancer
    2. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    3. What’s New in the Treatment of Oral and Head and Neck Cancer
    4. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    5. What’s New in the Treatment of Oral and Head and Neck Cancer
    6. Genomics and What’s New in the Treatment of Oral and Head and Neck Cancer
    7. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment
    8. Progress in the Treatment of Oral and Head and Neck Cancer

For Hodgkin Lymphoma

    1. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    2. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    3. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    4. What’s New in the Treatment of Hodgkin Lymphoma
    5. Update on CAR-T Cell Therapy
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Taking Your Blood Cancer Treatment on Schedule
    8. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Progress in the Treatment of Hodgkin Lymphoma
    11. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    12. Update on CAR-T Cell Therapy for People Living with Lymphoma
    13. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    14. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    15. Update on CAR-T Cell Therapy
    16. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Progress in the Treatment of Hodgkin Lymphoma
    18. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    19. Advances in Immunotherapy in the Treatment of Lymphoma

For Kidney Cancer

    1. Advances in the Treatment of Renal Cell Cancer
    2. Advances in the Treatment of Renal Cell Cancer

For Leukemia

    1. Current Perspectives on the Treatment of Chronic Lymphocytic Leukemia (CLL)
      Part II of Living with Chronic Lymphocytic Leukemia (CLL)
    2. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    3. Update on Chronic Lymphocytic Leukemia (CLL)
      Part I of Living with Chronic Lymphocytic Leukemia (CLL)
    4. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    5. Living with Acute Myelogenous Leukemia (AML)
    6. Progress in the Treatment of Myelodysplastic Syndrome (MDS)
    7. Living with Chronic Myelogenous Leukemia (CML)
    8. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Update on Chronic Lymphocytic Leukemia
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    11. Taking Your Blood Cancer Treatment on Schedule
    12. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    13. Updates in the Treatment of Acute Myelogenous Leukemia
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Living with Chronic Lymphocytic Leukemia
    16. Medical Update on Acute Myelogenous Leukemia (AML)
    17. Update on Chronic Lymphocytic Leukemia
      Part I of Living with Chronic Lymphocytic Leukemia
    18. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    19. Older Persons Living with Chronic Lymphocytic Leukemia
    20. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    21. Life with CLL: Taking Charge of Your Treatment Schedule
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    22. Managing Chronic Lymphocytic Leukemia and Its Complications
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    23. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    24. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    25. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
    26. Medical Update on Acute Myelogenous Leukemia (AML)
    27. Update on Chronic Lymphocytic Leukemia (CLL)
    28. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    29. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Liver Cancer

    1. Treatment Update on Liver Cancer
    2. Treatment Update on Liver Cancer and Managing the Cost of Care
    3. Treatment Update on Liver Cancer and Managing the Cost of Care
    4. Treatment Update on Liver Cancer

For Lung Cancer

    1. Update on Small Cell Lung Cancer Treatments
    2. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung Cancer
      Part II of Living with Lung Cancer
    3. Progress in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    4. Advances in the Treatment of Lung Cancer
      Part I of Life with Lung Cancer
    5. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung Cancer During the Holidays
      Part II of Life with Lung Cancer
    6. Progress in the Treatment of Lung Cancer
      Part I of Life with Lung Cancer
    7. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part II of Your Guide to the Latest Cancer Research and Treatment
    8. What’s New in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    9. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung Cancer
      Part II of Living with Lung Cancer
    10. What’s New in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    11. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    12. Advances in the Treatment of Mesothelioma
    13. Advances in the Treatment of Lung Cancer
      Part I of Living With Lung Cancer
    14. Advances in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    15. Update on Small Cell Lung Cancer Treatments
      Part I of Living with Small Cell Lung Cancer

For Lymphoma

    1. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    2. Treatment Update on Mantle Cell Lymphoma (MCL)
      Part I of Living with Mantle Cell Lymphoma
    3. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    4. Progress in the Treatment of Follicular Lymphoma
    5. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    6. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    7. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    8. What’s New in the Treatment of Hodgkin Lymphoma
    9. Treatment Update on Mantle Cell Lymphoma (MCL)
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    12. Taking Your Blood Cancer Treatment on Schedule
    13. The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    14. Update on Diffuse Large B-Cell Lymphoma
    15. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    16. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Progress in the Treatment of Hodgkin Lymphoma
    18. Update on Cutaneous T-Cell Lymphoma
    19. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    20. Update on Diffuse Large B-Cell Lymphoma
    21. Treatment Update on Mantle Cell Lymphoma
    22. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    23. Progress in the Treatment of Follicular Lymphoma
    24. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    25. Update on Marginal Zone Lymphoma
    26. Update on CAR-T Cell Therapy for People Living with Lymphoma
    27. Update on Mantle Cell Lymphoma
    28. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    29. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    30. Treatment Update on Mantle Cell Lymphoma (MCL)
    31. Progress in the Treatment of Waldenstrom’s Macroglobulinemia
    32. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    33. Update on Marginal Zone Lymphoma
    34. Update on Cutaneous T-Cell Lymphoma
    35. Progress in the Treatment of Follicular Lymphoma
    36. Progress in the Treatment of Hodgkin Lymphoma
    37. Treatment Update on Mantle Cell Lymphoma (MCL)
    38. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    39. Advances in Immunotherapy in the Treatment of Lymphoma

For Mantle Cell Lymphoma

    1. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    2. Treatment Update on Mantle Cell Lymphoma (MCL)
      Part I of Living with Mantle Cell Lymphoma
    3. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    4. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    5. Treatment Update on Mantle Cell Lymphoma (MCL)
    6. Update on CAR-T Cell Therapy
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Taking Your Blood Cancer Treatment on Schedule
    9. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    12. Treatment Update on Mantle Cell Lymphoma
    13. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    14. Update on Mantle Cell Lymphoma
    15. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    16. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    17. Treatment Update on Mantle Cell Lymphoma (MCL)
    18. Update on CAR-T Cell Therapy
    19. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    20. Treatment Update on Mantle Cell Lymphoma (MCL)
    21. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    22. Advances in Immunotherapy in the Treatment of Lymphoma

For Marginal Zone Lymphoma

    1. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    2. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    3. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    4. Update on CAR-T Cell Therapy
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Taking Your Blood Cancer Treatment on Schedule
    7. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    10. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    11. Update on Marginal Zone Lymphoma
    12. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    13. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    14. Update on CAR-T Cell Therapy
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. Update on Marginal Zone Lymphoma

For Melanoma

    1. Emerging Treatments for Metastatic Melanoma
      Part II of Life with Advanced Skin Cancer
    2. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part II of Your Guide to the Latest Cancer Research and Treatment
    3. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer
    4. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    5. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer

For Merkel Cell Carcinoma

    1. Treatment Perspectives on Merkel Cell Carcinoma (MCC)
      Part I of Living with Merkel Cell Carcinoma (MCC)

For Mesothelioma

    1. Advances in the Treatment of Mesothelioma
    2. Advances in the Treatment of Mesothelioma

For Metastatic Breast Cancer

    1. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    2. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    3. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    4. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    5. What’s New in the Treatment of Breast Cancer for Women of All Ages
    6. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer – Updates from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
    7. The Latest Developments Reported at the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer – Updates from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
    8. What’s New in the Treatment of Metastatic Breast Cancer
    9. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    10. Update on Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    11. The Latest Developments Reported at the 41st Annual San Antonio Breast Cancer Symposium (SABCS)
    12. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment
    13. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer
      Part II of Highlights from the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
    14. The Latest Developments Reported at the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Highlights from the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
    15. Advances in the Treatment of Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    16. Advances in the Treatment of HER2 Positive Breast Cancer

For Multiple Myeloma

    1. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    2. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    3. Progress in the Treatment of Multiple Myeloma
      Part I of Life with Multiple Myeloma
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Taking Your Blood Cancer Treatment on Schedule
    6. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Progress in the Treatment of Multiple Myeloma
    9. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Progress in the Treatment of Multiple Myeloma
    12. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Managing Symptoms and Treatment Side Effects of Multiple Myeloma
      Part III of Living with Multiple Myeloma

For Myelodysplastic Syndromes

    1. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    2. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    3. Progress in the Treatment of Myelodysplastic Syndrome (MDS)
    4. Taking Your Blood Cancer Treatment on Schedule
    5. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    6. Progress in the Treatment of Myelodysplastic Syndromes (MDS)

For Myelofibrosis

    1. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    2. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Taking Your Blood Cancer Treatment on Schedule
    5. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Myeloproliferative Neoplasms

    1. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    2. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    3. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Taking Your Blood Cancer Treatment on Schedule
    6. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part II of Your Guide to the Latest Cancer Research and Treatment
    9. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    10. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    11. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Non-Hodgkin Lymphoma

    1. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    2. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    3. Progress in the Treatment of Follicular Lymphoma
    4. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    5. Update on CAR-T Cell Therapy
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    8. Taking Your Blood Cancer Treatment on Schedule
    9. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Update on Cutaneous T-Cell Lymphoma
    12. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    13. Update on Diffuse Large B-Cell Lymphoma
    14. Treatment Update on Mantle Cell Lymphoma
    15. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    16. Progress in the Treatment of Follicular Lymphoma
    17. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    18. Update on Marginal Zone Lymphoma
    19. Update on CAR-T Cell Therapy for People Living with Lymphoma
    20. Update on Mantle Cell Lymphoma
    21. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    22. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    23. Treatment Update on Mantle Cell Lymphoma (MCL)
    24. Progress in the Treatment of Waldenstrom’s Macroglobulinemia
    25. Update on CAR-T Cell Therapy
    26. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    27. Update on Marginal Zone Lymphoma
    28. Update on Cutaneous T-Cell Lymphoma
    29. Progress in the Treatment of Follicular Lymphoma
    30. Treatment Update on Mantle Cell Lymphoma (MCL)
    31. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    32. Advances in Immunotherapy in the Treatment of Lymphoma

For Ovarian Cancer

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    2. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    3. Medical Update on Ovarian Cancer
    4. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment
    5. Medical Update on Ovarian Cancer
    6. Update on Advanced Ovarian Cancer

For Pancreatic Cancer

    1. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part II of Your Guide to the Latest Cancer Research and Treatment
    2. Treatment Update on Pancreatic Cancer
    3. Update on the Treatment of Pancreatic Cancer
    4. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    5. Update on the Treatment of Pancreatic Cancer

For Peripheral T-Cell Lymphoma

    1. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    2. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    3. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    4. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    5. Update on CAR-T Cell Therapy
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Taking Your Blood Cancer Treatment on Schedule
    8. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    11. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    12. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    13. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    14. Update on CAR-T Cell Therapy
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Advances in Immunotherapy in the Treatment of Lymphoma

For Polycythemia Vera

    1. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    2. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Taking Your Blood Cancer Treatment on Schedule
    5. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    8. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    9. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Prostate Cancer

    1. Advances in the Treatment of Metastatic Prostate Cancer
    2. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    3. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    4. For Caregivers: Coping with a Loved One’s Prostate Cancer
    5. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment
    6. Advances in the Treatment of Metastatic Prostate Cancer
      Part I of Living with Prostate Cancer

For Renal Cell Cancer

    1. Advances in the Treatment of Renal Cell Cancer
    2. Treatment Update on Renal Cell Cancer
    3. Advances in the Treatment of Renal Cell Cancer

For Sarcoma

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    2. Update on Soft Tissue Sarcoma
    3. Update on Rare Sarcomas
    4. Update on Soft Tissue Sarcoma
    5. Living with Gastrointestinal Stromal Tumors (GIST)

For Skin Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    2. Emerging Treatments for Metastatic Melanoma
      Part II of Life with Advanced Skin Cancer
    3. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Life with Advanced Skin Cancer
    4. Treatment Perspectives on Merkel Cell Carcinoma (MCC)
      Part I of Living with Merkel Cell Carcinoma (MCC)
    5. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer
    6. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    7. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer
    8. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Advanced Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer

For Small Lymphocytic Lymphoma

    1. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    2. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    3. Update on CAR-T Cell Therapy
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Taking Your Blood Cancer Treatment on Schedule
    6. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    9. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    10. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    11. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    12. Update on CAR-T Cell Therapy
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Advances in Immunotherapy in the Treatment of Lymphoma

For Squamous Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    2. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Life with Advanced Skin Cancer
    3. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Advanced Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer

For Stomach Cancer

    1. Current Perspectives in the Treatment of Metastatic Gastric Cancer

For Thyroid Cancer

    1. Update on Thyroid Cancer

For Triple Negative Breast Cancer

    1. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    2. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    3. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    4. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    5. Triple Negative Breast Cancer and African American Women
    6. What’s New in the Treatment of Breast Cancer for Women of All Ages
    7. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer – Updates from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
    8. The Latest Developments Reported at the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer – Updates from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
    9. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    10. Update on Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    11. The Latest Developments Reported at the 41st Annual San Antonio Breast Cancer Symposium (SABCS)
    12. The Latest Developments Reported at the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Highlights from the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
    13. Advances in the Treatment of Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer

For Waldenstrom’s Macroglobulinemia

    1. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    6. Progress in the Treatment of Waldenstrom’s Macroglobulinemia
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.